Efficacy and safety of plasma exchange in interstitial lung diseases with anti-melanoma differentiation-associated 5 gene antibody positive clinically amyopathic dermatomyositis-Reference-Cited by-同舟云学术

Efficacy and safety of plasma exchange in interstitial lung diseases with anti-melanoma differentiation-associated 5 gene antibody positive clinically amyopathic dermatomyositis

Published:2021-12-13 Issue: Volume: Page:1-7
ISSN:0300-9742
Container-title:Scandinavian Journal of Rheumatology
language:en
Short-container-title:Scandinavian Journal of Rheumatology

Author:

Komai T¹^ORCID,Iwasaki Y¹,Tsuchida Y¹,Hanata N¹,Tsuchiya H¹^ORCID,Harada Hiroaki¹,Hamasaki Y²,Nangaku M²,Shoda H¹,Fujio K¹

Affiliation:

1. Department of Allergy and Rheumatology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan

2. Division of Hemodialysis and Apheresis, The University of Tokyo Hospital, Tokyo, Japan

Publisher

Informa UK Limited

Subject

Immunology,General Medicine,Immunology and Allergy,Rheumatology

Link

https://www.tandfonline.com/doi/pdf/10.1080/03009742.2021.1995984

Reference19 articles.

1. Incidence of Dermatomyositis and Clinically Amyopathic Dermatomyositis

2. Tofacitinib for refractory interstitial lung diseases in anti-melanoma differentiation-associated 5 gene antibody-positive dermatomyositis

3. Successful treatment of anti-MDA5 antibody-positive refractory interstitial lung disease with plasma exchange therapy

4. Rituximab for refractory rapidly progressive interstitial lung disease related to anti-MDA5 antibody-positive amyopathic dermatomyositis

5. Prognostic Factors for Myositis-Associated Interstitial Lung Disease

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. 2023 American College of Rheumatology (ACR)/American College of Chest Physicians (CHEST) Guideline for the Treatment of Interstitial Lung Disease in People with Systemic Autoimmune Rheumatic Diseases;Arthritis & Rheumatology;2024-07-08

2. 2023 American College of Rheumatology (ACR)/American College of Chest Physicians (CHEST) Guideline for the Treatment of Interstitial Lung Disease in People with Systemic Autoimmune Rheumatic Diseases;Arthritis Care & Research;2024-07-08

3. Review of Pulmonary Manifestations in Antisynthetase Syndrome;Seminars in Respiratory and Critical Care Medicine;2024-05-06

4. Baricitinib for anti-melanoma differentiation-associated protein 5 antibody-positive dermatomyositis-associated interstitial lung disease: a case series and literature review on Janus kinase inhibitors for the disease;Rheumatology International;2024-03-08

5. Plasma exchange for anti-MDA5 antibody-positive dermatomyositis-associated rapidly progressive interstitial lung disease: A case report and literature review;Journal of International Medical Research;2023-09